Details for Patent: 7,541,350
✉ Email this page to a colleague
Summary for Patent: 7,541,350
Title: | Formulation containing anti-inflammatory androstane derivative |
Abstract: | There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) ##STR00001## or a solvate thereof. |
Inventor(s): | Biggadike; Keith (Stevenage, GB), Sayani; Amyn Pyarali (Mississauga, CA), Buxton; Ian Richard (Mississauga, CA), Reed; Kenton Lewis (Mississauga, CA) |
Assignee: | Glaxo Group Limited (Greenford, Middlesex, GB) |
Application Number: | 10/918,779 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Use; | More… ↓ |
Drugs Protected by US Patent 7,541,350
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,541,350
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 0019172.6 | Aug 05, 2000 |
International Family Members for US Patent 7,541,350
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1305329 | ⤷ Subscribe | 91429 | Luxembourg | ⤷ Subscribe |
European Patent Office | 1305329 | ⤷ Subscribe | CA 2008 00022 | Denmark | ⤷ Subscribe |
European Patent Office | 1305329 | ⤷ Subscribe | 300343 | Netherlands | ⤷ Subscribe |
European Patent Office | 1305329 | ⤷ Subscribe | SPC011/2008 | Ireland | ⤷ Subscribe |
European Patent Office | 1305329 | ⤷ Subscribe | 08C0014 | France | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |